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The rate of implantable cardioverter-deﬁbrillator (ICD) lead
perforations has been reported to be in the range of 0.6%–
5.2%, with the majority of cases occurring within 1 month of
implantation.1 However, isolated reports of delayed ICD
lead perforations occurring more than 1 year and up to 3
years after implantation have been described.2–4 Here, we
present a case of a patient with a Durata ICD lead who
presented with syncope and cardiac tamponade due to lead
perforation more than 1 year after implantation.
Case report
A 40-year-old man with a history of Brugada syndrome
underwent implantation of an ICD with a Durata 7122Q lead
(St. Jude Medical, St. Paul, MN) at an outside hospital. The
procedure was performed uneventfully. At the time of
implantation, the patient had a ventricular R-wave amplitude
of 11.9 mV, a pacing threshold of 1.0 V at 0.5 ms, and a
lead impedance of 508 Ω. He had an in-ofﬁce interrogation 8
months later, which revealed a ventricular R-wave amplitude
of 11.7 mV, a pacing threshold of 1.25 V at 0.5 ms, and a
lead impedance of 310 Ω.
Fourteen months after device implantation, he experi-
enced intermittent left shoulder pain. An echocardiogram
showed no pericardial effusion. He was admitted to our
hospital 2 weeks afterward with syncope. A transthoracic
echocardiogram showed a large pericardial effusion with
the deﬁbrillator lead tip lodged in the pericardial space
(Figure 1 and Online Supplemental Video). Device inter-
rogation revealed a decreased ventricular R-wave amplitudeKEYWORDS Deﬁbrillator lead; Cardiac perforation; Pericardial effusion
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).of 1.2 mV, an elevated right ventricular pacing threshold of
4.5 V at 0.5 ms, and a decreased lead impedance of 190 Ω
that had trended down from normal levels within a 1-month
period. Pericardiocentesis was performed, and 600 cm3 of
hemorrhagic ﬂuid was drained. The patient underwent
device and lead removal in a hybrid operating room without
need for further intervention and was discharged 2 days later.Discussion
To our knowledge, this case is the ﬁrst report of delayed
Durata lead perforation occurring more than 1 year after
implantation. Concerns about delayed cardiac perforations
with small diameter ICD leads, mainly involving the St. Jude
Riata lead, have been raised by single-center studies.5,6
In these series, all perforations occurred within 6 weeks of
lead implantation. Similarly, 2 previously published cases of
delayed cardiac perforation with the Durata lead occurred
within 6 weeks of implantation.7,8
The mechanism behind the marked delay (41 year) in the
occurrence of lead perforation in this patient is unclear. This
patient did not have known risk factors for lead perforation,Figure 1 Video still of an apical 4-chamber view of the transthoracic
echocardiogram of the case patient. Pericardial effusion is present along the
right ventricle with the Durata lead tip visualized in the pericardial space,
conﬁrming perforation.
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KEY TEACHING POINTS
 This case report describes a case of delayed
perforation of the Durata implantable cardioverter-
deﬁbrillator lead more than 1 year after
implantation.
 Lead perforation led to a late presentation of
pericardial effusion with cardiac tamponade.
 This case report highlights the importance of
continued vigilance for mechanical complications
of lead placement even more than 1 year after
implantation.
Heart Rhythm Case Reports, Vol 2, No 5, September 2016378such as steroid use, low body mass index, or older age.9 The
design of the Durata lead incorporates a curve along the right
ventricular shock coil with a ﬂanged silicone tip to reduce
lead tip pressure and potentially reduce the risk of cardiac
perforation. It has been postulated that the preformed slight
curvature of the Durata lead may lead to unpredictable
rotation of the lead body screw deployment that may lead to
perforation.10 In addition, despite the presence of a ﬂanged
silicone tip, the decreased lead diameter may still lead to
increased pressure at the lead tip, resulting in cardiac
perforation. Between the time of implantation and follow-
up 8 months later, that patient has a mild decrease in the lead
impedance and minimal elevation of the pacing threshold,
which may have reﬂected minimal migration of the lead tip.
It is possible that over time, with continued cardiac motion,
the lead gradually advanced into the pericardial space
over a period of several months before the acute formation
of a pericardial effusion and onset of symptoms. This
case underscores the importance of vigilance for delayedmechanical complications of ICD lead placement even more
than 1 year after lead implantation.
Appendix
Supplementary data
Supplementary data associated with this article can be found
in the online version at http://dx.doi.org/10.1016/j.hrcr.2016.
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